Functional and Personalised Hormone Restoration Therapy

ACTIVITY DESCRIPTION

Compounding hormone therapies and formulations present particular issues and challenges to the compounding pharmacist. The practice-based activity will provide compounding pharmacists with the opportunity to enhance their competency as it relates to the many therapeutic options used in hormone therapies.

Having been presented with a prescription indicating a need for a compounded medication, the participating pharmacist will use uniquely designed patient assessment tools, select appropriate delivery systems for the specific hormones and nutritional supplements prescribed, and then monitor patient progress. During this process the participant will have learned the physiologic features of the hormone systems in the body, how to conduct a patient needs analysis, and then work with physicians to provide pharmacist expertise with respect to the therapeutic, nutritional supplementation, and lifestyle and behavior modification options available to the physician.

Finally, participants will apply monitoring tools and strategies to maintain patient compliance with prescribed therapeutic initiatives. Case work will be documented and clinical findings recorded in a formal manner for purposes of confidential communication, record keeping and statistical analysis.

INTENDED AUDIENCE

Pharmacists engaged in prescription hormone compounding. For physicians, the above mentioned training activity may be applicable towards self-directed CPD as part of a structured learning plan.

ACTIVITY DESIGN

A two part activity; self-study with learning assessment and live event with case studies and competency assessment.

OVERALL LEARNING OBJECTIVES OF SELF-STUDY ACTIVITY

  1. Describe the hormone cascade.
  2. Describe the relative distribution of hormones in the body.
  3. Learn the physiological basis of hormone therapy.
  4. Learn the general hormone system functions; gonadal, adrenal and thyroid.
  5. Explain the female and male reproductive hormone system lifecycles.
  6. Review signs of female and male hormone imbalances.
  7. Describe principles of hormone functioning, relationships, and imbalance.
  8. Review test types, their advantages and disadvantages, used in hormone therapy.
  9. Review hormone therapy-related evidence-based medicine abstracts and citations.

OVERALL LEARNING OBJECTIVES OF LIVE ACTIVITY

  1. Evaluate and apply a unique set of rules applicable to customised hormone restoration therapy.
  2. Analyse physiological and biochemical features of endocrine system dysfunctions.
  3. Describe the hormone cascade, its neurobiological communication network, effects of exogenous and endogenous factors on the cascade, and impact on endocrine and neighbouring digestive and immune systems.
  4. Investigate and evaluate therapeutic alternatives for specific classifications related to hormone therapy and imbalance; specifically construct formulations, which may be prescribed or used by a healthcare provider in the treatment of perimenopause, menopause, andropause, thyroid dysfunction, adrenal dysfunction, metabolic syndrome, and sexual dysfunction.
  5. Interpret, integrate, and evaluate comprehensive patient assessment chart data; including prior medical history, familial history, differential diagnoses, lifestyle behaviours, signs and symptoms, and laboratory test results.
  6. Describe and design hormone-related medication options, adjunct pharmacotherapeutics, and nutraceutical treatments that are optimal and efficacious for the individual patient.
  7. Recognize and evaluate the various routes of delivery, delivery systems, dosage, forms and dispensing mechanisms used in hormone therapy, adjunct therapy, nutraceutical supplementation, and specific aspects of lifestyle management; and monitor patient responses through quantitative and qualitative systematic testing.

PHARMACIST COMPETENCIES

DOMAIN 4: Review and Supply Prescribed Medicines

  • Standard 4.2 - Consider appropriateness of prescribed medicines: gather relevant information; review prescribed medicines; promote optimal medication
  • Standard 4.3 - Dispense prescribed medicines: apply systematic dispensing procedure, manage records, assist consumer understanding

DOMAIN 5: Prepare Pharmaceutical Products

  • Standard 5.1 - Consider product requirements: consider legislative and professional obligations; consider need for product; confirm required information; confirm required formulation; determine if production requirements can be met; prepare and maintain product documentation; optimise packing and labelling
  • Standard 5.2 - Prepare non-sterile drug products: consider legislation, confirm preparation needed, prepare documentation, assemble ingredients, apply compounding principles, apply aseptic techniques, optimise packaging / labelling

DOMAIN 6: Deliver Primary and Preventive Health Care

  • Standard 6.1 - Assess primary health care needs: assess primary health care needs: elicit clinical information; identify management options, initiate collaboration or onward referral

DOMAIN 7: Promote and Contribute to Optimal Use of Medicines

  • Standard 7.1 - Contribute to therapeutic decision-making: obtain accurate medication history; assess current medication management recommend change in medication management; support and assist consumer self-management
  • Standard 7.2 - Provide ongoing medication management: seek consumer support; review clinical progress; initiate monitoring and intervention; manage records

DOMAIN 3: Medicines Management and Patient Care

  • Standard 3.1 - Develop a patient centred, culturally responsive approach to medication management: obtain relevant health and medicines information, assess medication management practices and needs, collaborate to develop a medication management strategy or plan
  • Standard 3.2 - Implement the medication management strategy or plan: administer medicines, provide primary care and promote judicious use of medicines, dispense medicines (including compounded medicines) in consultation with the patient and / or prescriber, prescribe medicines, provide counselling and information for safe and effective medication management, facilitate continuity of care including during transitions of care
  • Standard 3.3 - Monitor and evaluate medication management: undertake a clinical review, apply clinical review findings to improve health outcomes, document clinical review findings and changes in medication management
  • Standard 3.4 - Compound medicines: determine the required formulation, confirm the availability of suitable resources, apply risk management strategies, prepare products non-aseptically, prepare products aseptically, prepare cytotoxic or other hazardous drug products, complete appropriate documentation, optimise packaging and supplementary labelling

ACCREDITATION

This activity has been accredited for 6.5 hrs of Group 1 CPD (or 6.5 CPD credits) for the home study activity, suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 6.5 hrs of Group 2 CPD (or 13.0 CPD credits) upon successful completion of relevant assessment activities PLUS 15.0 hours of Group 1 CPD (15.0 CPD credits) for the live event, suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 15.0 hrs of Group 2 CPD (30.0 CPD credits) upon participation in required interactive workshop activities and successful completion of assessment activities.

APC Accredited CPD

A1709MED: The activity accreditation expires 25 September 2019.

EDITORS

CATHMAR ROSS, MB, ChB

QI & CPD Reviewer
Disclosure: Consultant, LP3 Network

DAPHNEE LALONDE, BSc, MSc

Continuing Education Supervisor, LP3
Disclosure: Consultant, MEDISCA Inc.

PATRICIA ULLMANN, BPharm

Training and Technical Services Manager, MEDISCA Australia.

SHANNON BELLEVUE, BSc, MSc

Medical Writer, LP3 Network


FACILITATORS

TARA SCOTT, MD, FACOG

Certified Menopause Practitioner, NAMS.
Fellow of American College of OB/GYN, Advanced Fellow and certified in Anti-aging, Regenerative, and Functional Medicine, Certified Menopause Practitioner through the North American Menopause Society, Clinical Assistant Professor of OB/GYN at Northeast Ohio Medical University, Chief Medical Officer, Revitalize Medical Group.

KEN SPEIDEL, BS Pharm, PharmD, RPh, FIACP, FACA

Senior Associate, Gates Healthcare Associates
Independent industry consultant to organisations in North America and Senior Associate for; Gates Healthcare Associates and Health System Consulting Group; Specialty Training in Functional Medicine, Endocrinology, Pain Management and Aseptic compounding; Surveyor and Standards Committee member for PCAB.


Other Facilitators may also be involved in the presentation of the Training Activity.

COPYRIGHT

Activity material is Copyright© 2008-2019 LP3 Network Inc.

COMPLETION REQUIREMENTS

Activity participants are required to achieve a 75% passing grade associated with a self-study learning assessment prior to attending the live event. Full attendance and the completion of a program evaluation and practical skill set competency evaluation are a compulsory requirement to achieve credit for the live event.

DECLARATIONS AND DISCLOSURES

This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA AUSTRALIA ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.

FINANCIAL SUPPORT

An unrestricted educational grant for this activity has been provided by MEDISCA Inc.

HOTEL ACCOMMODATIONS

Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the activity participant.

FOOD AND BEVERAGE

As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.

CANCELLATION AND REFUND POLICY

A written request must be sent to MEDISCA Australia requesting a ‘Cancellation without Transfer’ to an alternate live activity event date. If cancellation occurs at greater than or equal to 31 days from the live activity event date, then the registrant will receive a 75% refund; 15-30 days is a 50% refund; and less than or equal to 14 days will result in no refund.

TRANSFER POLICY

The transfer policy is only in effect if requested less than or equal to 15 days post original live activity event date. Failure to submit the “Transfer Request” within 15 days post original live activity event date will default to the “Cancellation and Refund Policy”. The transfer policy can only be applied one (1) time. Transfer to a new live activity event date must be within the current calendar year. Failure to attend the new live activity event will result in no refund and will no longer be transferable. Confirmation of the new activity date is subject to approval by MEDISCA Australia based on the number of available seats within the selected live activity event.


GO BACK


X

We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.



Copyright® 1986-2019 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified